Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is Correlated With Fibroblast Growth Factor 23: Sub-Analysis Results of the ETACAR-HD Study

Secondary hyperparathyroidism in chronic kidney disease poses a major risk factor for vascular calcification and high bone turnover, leading to mineralization defects. The aim was to analyze the effect of active vitamin D and calcimimetic treatment on fibroblast growth factor 23 (FGF23), serum calci...

Descripción completa

Detalles Bibliográficos
Autores principales: Dörr, Katharina, Hödlmoser, Sebastian, Kammer, Michael, Reindl-Schwaighofer, Roman, Lorenz, Matthias, Reiskopf, Bianca, Jagoditsch, Rahel, Marculescu, Rodrig, Oberbauer, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299083/
https://www.ncbi.nlm.nih.gov/pubmed/35872799
http://dx.doi.org/10.3389/fmed.2022.948177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299083/
https://www.ncbi.nlm.nih.gov/pubmed/35872799
http://dx.doi.org/10.3389/fmed.2022.948177

Ejemplares similares